STOCK TITAN

Olaplex Holdings (OLPX) 10-K Filings

OLPX

Here are the 10-K annual reports from Olaplex Holdings, Inc. (OLPX) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow OLPX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OLPX filings page.

Rhea-AI Summary

Olaplex Holdings, Inc. filed Amendment No. 1 to its Annual Report for the year ended December 31, 2025 to add detailed disclosures on directors, corporate governance and 2025 executive compensation. The filing shows non-affiliate voting stock market value of $198.1 million as of June 30, 2025 and 672,042,176 shares outstanding as of April 20, 2026.

Olaplex describes its status as a Nasdaq “controlled company,” related committee exemptions, and an Information Security Subcommittee focused on cybersecurity and artificial intelligence. The Compensation Discussion and Analysis outlines 2025 net sales of $423 million and adjusted EBITDA of $94 million, producing annual bonuses at 103% of target for named executives, alongside large time-vested RSU grants and robust stock ownership, anti-hedging and clawback policies.

Rhea-AI Summary

Olaplex Holdings, Inc. is a prestige haircare company built around patent-protected bond-building technology used by professional stylists and consumers. The brand began with in-salon treatments and an at-home product and has expanded to roughly 30 SKUs aimed at holistic hair health, addressing chemical, thermal and everyday damage.

The company sells through three interconnected channels: professional distributors and salons, specialty beauty retailers, and direct-to-consumer via Olaplex.com and third‑party e-commerce. In 2025, about 48% of net sales were in the U.S. and 52% international, with one customer representing 18% of net sales. Manufacturing is fully outsourced, with one supplier accounting for more than half of 2025 net sales and inventory purchases.

Olaplex highlights a business transformation plan, a refreshed packaging rollout, and a rebuilt innovation engine. In 2025 it launched several new products, including fine-hair shampoos and conditioners, scalp and mask treatments, and acquired Purvala Bioscience to deepen science-based innovation. The company reports over 180 issued patents worldwide and emphasizes competitive, regulatory, supply chain, brand, cybersecurity and transformation execution risks.